OOIR: Observatory of International Research

Papers

(The TQCC of Rheumatic Disease Clinics of North America is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Pediatric Rheumatology Comes of Age: Part II	79
Lessons from Cardiac and Vascular Biopsies from Patients with and without Inflammatory Rheumatic Diseases	62
Implementation Science in Pediatric Rheumatology: A Path to Health Equity	46
Contents	37
Immune Checkpoint Inhibitor-induced Inflammatory Arthritis	33
Copyright	33
Advancing Gastrointestinal Microbiota Research in Systemic Sclerosis	25
Kawasaki Disease and Multisystem Inflammatory Syndrome in Children	22
Molecular Pathways in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis	22
Osteoarthritis Treatment Guidelines from Six Professional Societies	21
Forthcoming Issues	20
Exploring the Mucosal Immune Response in Axial Spondyloarthritis Through Immunoglobulin A-Coated Microbiota	19
COPA Syndrome from Diagnosis to Treatment	19
Impact of Non-steroidal Anti-inflammatory Drugs, Glucocorticoids, and Disease-Modifying Anti-Rheumatic Drugs on Cancer Response to Immune Checkpoint Inhibitor Therapy	19
Copyright	18
Why It Hurts	17
Immune Checkpoint Inhibitor-induced Polymyalgia Rheumatica	17
Contributors	16
B Cells in Systemic Lupus Erythematosus	15
The Short and Long of COVID-19	15
Venous Thromboembolism in the Inflammatory Rheumatic Diseases	14
Newer Immunosuppressants for Rheumatologic Disease	13
Imaging Challenges and Developments in Large-vessel Vasculitis	13
Contents	13
T Cells in Systemic Lupus Erythematosus	13

Vaccinations in Patients with Rheumatic Disease	13
Taxonomy of Quality of Care Indicators	13
Lessons Learned from the COVID-19 Pandemic in Rheumatology	13
Contents	12
It Takes Oysters to Generate Pearls	12
Primary Cardiac Involvement in Systemic Sclerosis	12
De novo Connective Tissue Disorders as Immune-related Adverse Events	11
Multisystem Inflammatory Syndrome in Children and Kawasaki Disease	11
Pulmonary Hypertension Associated with Connective Tissue Disease	10
The Utility of Laboratory Investigations for the Assessment and Management of Rheumatic Immune Related Adverse Events	10
Expanding the Treatment Team	10
Uveitis in Children and Adolescents	9
Low Back Pain in Adolescent and Geriatric Populations	9
Scleroderma: Best Approaches to Patient Care	9
Copyright	9
Clinically Relevant Biomarkers in Connective Tissue Disease-Associated Interstitial Lung Disease	8
Rheumatology Pearls for the Primary Care Physician	8
Managing Immunosuppression in Vasculitis Patients in Times of Coronavirus Disease 2019	8
COVID-19 and Rheumatology	8
Mimickers of Immune Checkpoint Inhibitor-induced Inflammatory Arthritis	8
Assessing Patient-Reported Outcomes in Pediatric Rheumatic Diseases	8
Charles L Christian	7
Daniel J McCarty, MD: A Giant of Rheumatology	7
Cardiac MRI in Rheumatic Disease	7
Contributors	6
Contributors	6
Preventative Care in Scleroderma	6
A Guide to Contemporary Clinical Practice Guidelines	6
Chronic Nonbacterial Osteomyelitis	6
Heart Failure in Rheumatic Disease	6
Guideline Development and Implementation in Rheumatic Disease	6
Systemic Lupus Erythematosus Classification and Diagnosis	6
Contents	5
E Carwile LeRoy, MD	5
Imaging of Pulmonary Manifestations of Connective Tissue Disease	5
Therapeutic Advances in Eosinophilic Granulomatosis with Polyangiitis	5
Forthcoming Issues	5
Antinuclear Antibody Testing for the Diagnosis of Systemic Lupus Erythematosus	5
The Giants of Rheumatology at Johns Hopkins: Lawrence E Shulman, MD, PhD and Mary Betty Stevens, MD	5
The Impact of Pediatric Rheumatic Diseases on Sexual Health, Family Planning, and Pregnancy	5
Copyright	5
The Power of Systems Biology	5
Copyright	5
Imaging of the Major Salivary Glands in Rheumatic Disease	5
Contributors	5
Biomarkers in Childhood-Onset Systemic Lupus Erythematosus	5
Beyond Coronary Artery Disease	5
Treatment Guidelines in Gout	4
Cardiovascular Health in Pediatric Rheumatologic Diseases	4
Cardiovascular Comorbidities in Inflammatory Rheumatic Diseases	4

The Role of Psychology in Pediatric Rheumatic Diseases	4
Genetic Defects in Early-Onset Inflammatory Bowel Disease	4
Updates in Systemic Sclerosis Treatment and Applicability to Pediatric Scleroderma	4
Treatment Guidelines in Pediatric Rheumatic Diseases	4
Cardiovascular Comorbidities in Inflammatory Rheumatic Diseases	4
Patient Engagement in Pediatric Rheumatology Research	4
CARRA	4
Copyright	4
Environmental Triggers for Rheumatic Disease: From “Why Did I Get This?” to “How Can We Prevent This?”	4
Role of Environment in Pediatric Rheumatic Diseases	4